This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Leo Joyce, phD
Director, Analytical Department at Arrowhead Pharmaceuticals
Speaker

Profile

Leo Joyce is the Director of Analytical Development at Arrowhead Pharmaceuticals, where he leads analytical strategy and method development efforts in support of siRNA-based therapeutics. Since joining Arrowhead in 2019, Dr. Joyce has played a pivotal role in advancing analytical methodologies for oligonucleotide characterization, beginning with hands-on method development in the laboratory. He started his industry career at Merck, focusing on stereochemical analysis techniques for small molecule drug candidates. Dr. Joyce earned his Ph.D. in organic chemistry from the University of Texas at Austin in 2012 and has authored more than 45 scientific publications spanning analytical chemistry, structural elucidation, and drug development.

Agenda Sessions

  • Characterization of Partially Phosphorothiolated Oligonucleotides: Analytical Strategies for CMC Support

    15:00

At this event